Bioengineering of novel organotypic 3D human liver tissue model for drug-induced liver injury and toxicity studies
BackgroundIn drug development, liver failure is the cause of approximately 30% of post marketing withdrawals of pharmaceuticals. Drug-induced liver injury (DILI) remains the leading cause of acute liver failure (ALF), accounting for approximately 15% of the cases.Materials and methodsIn this study,...
Saved in:
| Main Authors: | Camden Holm, Joseph Finelli, Mateo Frare, Alex Armento, Seyoum Ayehunie |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Toxicology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/ftox.2025.1574387/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perspective: How complex in vitro models are addressing the challenges of predicting drug-induced liver injury
by: K. Taylor, et al.
Published: (2025-02-01) -
Hepatotoxicity evaluation of cannabidiol, cannabinol, cannabichromene and cannabigerol using a human quad culture liver chip
by: Jacob D. Larson, et al.
Published: (2025-08-01) -
Liver Injury Associated with Antituberculosis Medications
by: Syifa Mustika, et al.
Published: (2025-07-01) -
Exploring drug-induced liver injury: comprehensive insights into mechanisms and management of hepatotoxic agents
by: Ahmed K. Saleh, et al.
Published: (2025-03-01) -
Hepatotoxicity Associated with Adalimumab in Hidradenitis Suppurativa: A Report of Two Cases of Drug-Induced Liver Injury
by: Cristian Fernando Caballero-Linares, et al.
Published: (2025-07-01)